Corteva experienced an after-tax net loss of $322 million in the third quarter. That compares to profits one year ago of $36 million. Seed sales increased five percent and crop protection sales rose 22 percent. For the first nine months of the year, sales of the Enlist system totaled $1.1 billion. That’s an increase of 80 percent from the same time period last year. The company expects market penetration in the United States for the Enlist E3 technology to be in the mid-50 percent range. The percentage of Enlist with proprietary Corteva germplasm is expected to reach 65 percent in 2023.
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.